New Business Model to bring innovation to children with cancer
Cancer in children remains a major source of suffering: in Europe ~35,000 children are diagnosed with, and ~6,000 children die from cancer each year. Despite major advances in cancer […]
ME-TA opleiding 2023-2024 “economische evaluaties van medische interventies” (Leuven en St-M. Latem)
Graag informeren wij u over de 3-daagse training “Economische evaluaties van medische interventies: gerichte training voor onderzoekers, evaluatoren en doe-het-zelvers”.
Deze interessante en interactieve training wordt in het Nederlands gegeven […]
“La Médecine d’après, leçons du Covid 19”
In this essay, Michel Goldman discusses the lessons from the pandemic that should influence medicine as a whole. After tracing the evolution of anti-infective strategies, he explains […]
Financial Intermediation and the Funding of Biomedical Innovation: A Review by Andrew W. Lo and Richard T. Thakor
A key paper on financing biomedical innovation: link here.
Review of literature on financial intermediation in the process by which new medical therapeutics are financed, developed, and delivered. […]
International Conference – Decentralisation of health care : European experiences
DULBEA, Solidaris & CIRIEC – 16th of November – Dupréel Room (ULB Solbosch)
In collaboration with Solidaris and CIRIEC, the DULBEA is organising an international conference on the 16th of November 2022 […]
Register now to the Interdisciplinary Program
Registrations for the 8th edition of the Interdisciplinary Program is now open.
Full program will be available soon.
Please find all the information on our dedicated page: here […]
Article: Covid long: portrait du grand imitateur du 21e siècle
Le Pr Michel Goldman (Professeur émérite d’immunologie et président de l’Institut interdisciplinaire pour l’innovation en santé à l’ULB) vient de publier un article consacré au Covid long dans Frontiers […]
Quel intérêt pour le dosage des anticorps anti-Covid ?
Quel intérêt pour le dosage des anticorps anti-Covid ? Ci-dessous les réponses de Michel Goldman à Laurence Dardenne dans La Libre.
- Comment mesure-t-on le taux […]
Register now to the conference: Build tomorrow’s healthcare for all European citizen
Register now to the Round table of the HealthTech Innovation Days: “Build tomorrow’s healthcare for all European citizen”
The conference will take place on […]
Improving the innovation/access trade-off for rare diseases in the EU after Covid-19
Scientific progress in the treatment of rare diseases is both an opportunity to improve lives and a financial challenge given the high cost of therapies. As stressed by […]